Overcoming tolerance in hepatitis B virus transgenic mice: A possible involvement of regulatory T cells

Microbiology and Immunology

Volumn 47, Issue 6, 2003, Pages 453-460

  Roh, Sujin ^a   Kim, Kilhyoun ^a  

^a Ewha Womans University   (South Korea)

Author keywords

HBV; Regulatory T cell; Tolerance; Transgenic mouse

Indexed keywords

CYTOKINE; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIGEN;

ADOLESCENT; ADOPTIVE TRANSFER; AGED; ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION SYSTEM; HEPATITIS B; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; LIVER DISEASE; MOUSE; MOUSE STRAIN; NONHUMAN; T LYMPHOCYTE; TH1 CELL; TRANSGENIC MOUSE; VACCINIA VIRUS;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; MUS MUSCULUS; VACCINIA VIRUS;

EID: 0037633049     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03370.x     Document Type: Article

References (21)

1. Alexander, J., Fikes, J., Hoffman, S., Franke, E., Appella, E., Chisari, F.V., Guidotti, L.G., Chesnut, R.W., Livingston, B., and Sette, A. 1998. The optimization of helper T lymphocyte (HTL) function in vaccine development. Immunol. Res. 18: 79-92.
2. Ando, K., Moriyama, T., Guidotti, L.G., Wirth, S., Schreiber, R.D., Schilicht, H.J., Huang, S., and Chisari, F.V. 1993. Cytotoxic T lymphocyte induced fulminant hepatitis in hepatitis B surface antigen transgenic mice. A paradigm for class I restricted immunopathology. J. Exp. Med. 178: 1541-1546.
3. Chisari, F.V. 1996. Hepatitis B virus transgenic mice: model of viral immunobiology and pathogenesis, p. 149-173. In Chisari, F.V., and Oldstone, M.B.A. (eds), Transgenic models of human viral and immunological disease, Springer, Berlin.
4. Chisari, F.V., and Ferrari, C. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13: 29-60.
5. Chisari, F.V., Filippi, P., Buras, J., McLachlan, A., Popper, H., Pinkert, C.A., Palmiter, R.D., and Brinster, R.L. 1987. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 84: 6909-6913.
6. Chisari, F.V., Filippi, P., McLachlan, A., Milich, D.R., Riggs, M., Lee, S., Palmiter, R.D., Pinkert, C.A., and Brinster, R.L. 1986. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 60: 880-887.
7. Chisari, F.V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H.A., Sell, S., Pinkert, C.A., Brinster, R.L., and Palmiter, R.D. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145-1156.
8. Gaecia, S., DiSanto, J., and Stockinger, B. 1999. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 11: 163-171.
9. Gilles, P.N., Fey, G., and Chisari, F.V. 1992. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66: 3955-3960.
10. Guidotti, L.G., Ishikawa, T., Hobbs, M.V., Matzke, B., Schreiber, R.D., and Chisari, F.V. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 25-36.
11. Kakimi, K., Isogawa, M., Chung, J., Sette, A., and Chisari, F.V. 2002. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 76: 8609-8620.
12. Livingston, B.D., Alexander, J., Crimi, C., Oseroff, C., Celis, E., Daly, K., Guidotti, L.G., Chisari, F.V., Fikes, J., Chesnut, R.W., and Sette, A. 1999. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J. Immunol. 162: 3088-3095.
13. Moriyama, T., Guilhot, S., Klopchin, K., Moss, B., Pinkert, C.A., Palmiter, R.D., Brinster, R.L., Kanagawa, O., and Chisari, F.V. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248: 361-364.
14. Roh, S., Lee, Y.-K., Ahn, B.-Y., Kim, K., and Moon, A. 2001. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses. Virus Res. 73: 17-26.
15. Schirmbeck, R., Wild, J., Stober, D., Blum, H.E., Chisari, F.V., Geissler, M., and Reimann, J. 2000. Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen. J. Immunol. 164: 4235-4243.
16. Shevach, E.M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18: 423-449.
17. Shimizu, Y., Guidotti, L.G., Fowler, P., and Chisari, F.V. 1998. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161: 4520-4529.
18. Suzuki, H., Zhou, Y.W., Kato, M., Mak, T.W., and Nakashima, I. 1999. Normal regulatory a/b T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor b in vivo. J. Exp. Med. 190: 1561-1571.
19. Svetic, A., Finkelman, F.D., Jian, Y.C., Dieffenbach, C.W., Scott, D.E., McCarthy, K.F., Steinberg, A.D., and Gause, W.C. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147: 2391-2397.
20. Tsui, L.V., Guidotti, L.G., Ishikawa, T., and Chisari, F.V. 1995. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 92: 12398-12402.
21. Wirth, S., Guidotti, L.G., Ando, K., Schlich, H.J., and Chisari, F.V. 1995. Breaking tolerance leads to autoantibody production but not antoimmune liver disease in hepatitis B virus envelope transgenic mice. J. Immunol. 154: 2504-2515.